We have located links that may give you full text access.
Peripheral Antinociception Induced by Aripiprazole Is Mediated by the Opioid System.
BACKGROUND: Aripiprazole is an antipsychotic drug used to treat schizophrenia and related disorders. Our previous study showed that this compound also induces antinociceptive effects. The present study aimed to assess the participation of the opioid system in this effect.
METHODS: Male Swiss mice were submitted to paw pressure test and hyperalgesia was induced by intraplantar injection of prostaglandin E2 (PGE2 , 2 μ g). Aripiprazole was injected 10 min before the measurement. Naloxone, clocinnamox, naltrindole, nor-binaltorphimine, and bestatin were given 30 min before aripiprazole. Nociceptive thresholds were measured in the 3rd hour after PGE2 injection.
RESULTS: Aripiprazole (100 μ g/paw) injected locally into the right hind paw induced an antinociceptive effect that was blocked by naloxone (50 μ g/paw), a nonselective opioid receptor antagonist. The role of μ -, δ -, and κ -opioid receptors was investigated using the selective antagonists, clocinnamox (40 μ g/paw), naltrindole (15, 30, and 60 μ g/paw), and nor-binaltorphimine (200 μ g/paw), respectively. The data indicated that only the δ -opioid receptor antagonist inhibited the peripheral antinociception induced by aripiprazole. Bestatin (400 μ g), an aminopeptidase-N inhibitor, significantly enhanced low-dose (25 μ g/paw) aripiprazole-induced peripheral antinociception.
CONCLUSION: The results suggest the participation of the opioid system via δ -opioid receptor in the peripheral antinociceptive effect induced by aripiprazole.
METHODS: Male Swiss mice were submitted to paw pressure test and hyperalgesia was induced by intraplantar injection of prostaglandin E2 (PGE2 , 2 μ g). Aripiprazole was injected 10 min before the measurement. Naloxone, clocinnamox, naltrindole, nor-binaltorphimine, and bestatin were given 30 min before aripiprazole. Nociceptive thresholds were measured in the 3rd hour after PGE2 injection.
RESULTS: Aripiprazole (100 μ g/paw) injected locally into the right hind paw induced an antinociceptive effect that was blocked by naloxone (50 μ g/paw), a nonselective opioid receptor antagonist. The role of μ -, δ -, and κ -opioid receptors was investigated using the selective antagonists, clocinnamox (40 μ g/paw), naltrindole (15, 30, and 60 μ g/paw), and nor-binaltorphimine (200 μ g/paw), respectively. The data indicated that only the δ -opioid receptor antagonist inhibited the peripheral antinociception induced by aripiprazole. Bestatin (400 μ g), an aminopeptidase-N inhibitor, significantly enhanced low-dose (25 μ g/paw) aripiprazole-induced peripheral antinociception.
CONCLUSION: The results suggest the participation of the opioid system via δ -opioid receptor in the peripheral antinociceptive effect induced by aripiprazole.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app